CA Stock MarketDetailed Quotes

Rakovina Therapeutics Inc (RKV)

Watchlist
  • 0.110
  • -0.010-8.33%
15min DelayMarket Closed Jan 15 16:00 ET
2.33MMarket Cap-0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Rakovina Therapeutics Inc (RKV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.87%-1.04M
-588.62%-3.03M
-377.35%-1.24M
-107.07%-3.86M
-366.74%-1.76M
-253.22%-1.4M
45.03%-439.79K
10.41%-259.13K
2.88%-1.86M
16.21%-377.02K
Net income from continuing operations
-68.34%-1.71M
-253.03%-2.9M
-189.72%-2.18M
-55.86%-4.07M
-105.32%-1.48M
-56.92%-1.02M
-36.52%-821.06K
-17.23%-752.38K
6.39%-2.61M
-11.64%-722.76K
Operating gains losses
----
----
----
--18.82K
----
----
----
----
----
----
Depreciation and amortization
0.00%135.13K
0.00%133.66K
-1.10%132.19K
0.27%537.58K
0.00%135.13K
0.00%135.13K
0.00%133.66K
1.11%133.66K
0.00%536.11K
0.00%135.13K
Remuneration paid in stock
1,990.37%380.7K
--0
544.79%217.35K
-34.31%84.92K
-57.34%16.16K
-28.49%18.21K
-33.62%16.84K
-16.91%33.71K
-50.00%129.28K
-10.33%37.87K
Other non cashItems
274.74%83.17K
-5.94%38.82K
15.33%23.01K
105.99%127.04K
17.61%43.63K
21.19%22.19K
--41.27K
--19.95K
--61.67K
--37.1K
Change In working capital
113.44%74.83K
-259.55%-302.34K
86.43%570.35K
-2,380.67%-550.87K
-460.80%-489.43K
-866.16%-556.88K
152.06%189.5K
70.15%305.94K
-69.71%24.15K
573.61%135.65K
-Change in receivables
64.53%-35.97K
-168.91%-57.91K
1,410.30%21.84K
-1,078.89%-61.26K
1,572.29%60.24K
-182.83%-101.4K
83.96%-21.53K
-52.06%1.45K
-108.79%-5.2K
82.56%3.6K
-Change in prepaid assets
151.36%126.65K
91.43%-44.66K
-50.52%71.82K
-3,698.75%-693.23K
-143.70%-70.41K
-180.69%-246.62K
-152.57%-521.34K
26.33%145.14K
-166.31%-18.25K
2.06%161.14K
-Change in payables and accrued expense
92.40%-15.86K
-127.28%-199.77K
199.14%476.7K
327.77%203.62K
-1,547.61%-479.26K
-647.92%-208.86K
3,238.91%732.37K
157.44%159.36K
786.76%47.6K
79.18%-29.09K
Cash from discontinued investing activities
Operating cash flow
25.87%-1.04M
-588.62%-3.03M
-377.35%-1.24M
-107.07%-3.86M
-366.74%-1.76M
-253.22%-1.4M
45.03%-439.79K
10.41%-259.13K
2.88%-1.86M
16.21%-377.02K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-109.57%-25.39K
237.68%4.73M
281,738,200.00%2.82M
265.21K
65,071.77%1.4M
1
Net issuance payments of debt
--0
----
----
--0
--0
--0
----
----
--1.51M
--0
Net common stock issuance
-89.84%60.96K
----
----
--4.92M
--2.93M
--600K
----
----
--0
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
--0
----
Net other financing activities
74.21%-86.35K
----
----
-67.04%-188.43K
-10,761,800.00%-107.62K
---334.79K
----
----
---112.81K
--1
Cash from discontinued financing activities
Financing cash flow
-109.57%-25.39K
----
----
237.68%4.73M
281,738,200.00%2.82M
--265.21K
----
----
65,071.77%1.4M
--1
Net cash flow
Beginning cash position
35.81%1.88M
-57.21%75.82K
200.87%1.31M
-51.35%436.31K
-68.64%255.05K
14.70%1.39M
-70.84%177.19K
-51.35%436.31K
-68.10%896.83K
-39.61%813.33K
Current changes in cash
6.25%-1.06M
49.45%1.81M
-377.35%-1.24M
290.31%876.43K
380.54%1.06M
-186.14%-1.13M
101.16%1.21M
10.41%-259.13K
75.95%-460.52K
16.21%-377.02K
End cash Position
222.41%822.29K
35.81%1.88M
-57.21%75.82K
200.87%1.31M
200.87%1.31M
-68.64%255.05K
14.70%1.39M
-70.84%177.19K
-51.35%436.31K
-51.35%436.31K
Free cash from
25.87%-1.04M
-588.62%-3.03M
-377.35%-1.24M
-107.07%-3.86M
-366.74%-1.76M
-253.22%-1.4M
45.03%-439.79K
10.41%-259.13K
2.88%-1.86M
16.21%-377.02K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.87%-1.04M-588.62%-3.03M-377.35%-1.24M-107.07%-3.86M-366.74%-1.76M-253.22%-1.4M45.03%-439.79K10.41%-259.13K2.88%-1.86M16.21%-377.02K
Net income from continuing operations -68.34%-1.71M-253.03%-2.9M-189.72%-2.18M-55.86%-4.07M-105.32%-1.48M-56.92%-1.02M-36.52%-821.06K-17.23%-752.38K6.39%-2.61M-11.64%-722.76K
Operating gains losses --------------18.82K------------------------
Depreciation and amortization 0.00%135.13K0.00%133.66K-1.10%132.19K0.27%537.58K0.00%135.13K0.00%135.13K0.00%133.66K1.11%133.66K0.00%536.11K0.00%135.13K
Remuneration paid in stock 1,990.37%380.7K--0544.79%217.35K-34.31%84.92K-57.34%16.16K-28.49%18.21K-33.62%16.84K-16.91%33.71K-50.00%129.28K-10.33%37.87K
Other non cashItems 274.74%83.17K-5.94%38.82K15.33%23.01K105.99%127.04K17.61%43.63K21.19%22.19K--41.27K--19.95K--61.67K--37.1K
Change In working capital 113.44%74.83K-259.55%-302.34K86.43%570.35K-2,380.67%-550.87K-460.80%-489.43K-866.16%-556.88K152.06%189.5K70.15%305.94K-69.71%24.15K573.61%135.65K
-Change in receivables 64.53%-35.97K-168.91%-57.91K1,410.30%21.84K-1,078.89%-61.26K1,572.29%60.24K-182.83%-101.4K83.96%-21.53K-52.06%1.45K-108.79%-5.2K82.56%3.6K
-Change in prepaid assets 151.36%126.65K91.43%-44.66K-50.52%71.82K-3,698.75%-693.23K-143.70%-70.41K-180.69%-246.62K-152.57%-521.34K26.33%145.14K-166.31%-18.25K2.06%161.14K
-Change in payables and accrued expense 92.40%-15.86K-127.28%-199.77K199.14%476.7K327.77%203.62K-1,547.61%-479.26K-647.92%-208.86K3,238.91%732.37K157.44%159.36K786.76%47.6K79.18%-29.09K
Cash from discontinued investing activities
Operating cash flow 25.87%-1.04M-588.62%-3.03M-377.35%-1.24M-107.07%-3.86M-366.74%-1.76M-253.22%-1.4M45.03%-439.79K10.41%-259.13K2.88%-1.86M16.21%-377.02K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -109.57%-25.39K237.68%4.73M281,738,200.00%2.82M265.21K65,071.77%1.4M1
Net issuance payments of debt --0----------0--0--0----------1.51M--0
Net common stock issuance -89.84%60.96K----------4.92M--2.93M--600K----------0--0
Proceeds from stock option exercised by employees ----------------------------------0----
Net other financing activities 74.21%-86.35K---------67.04%-188.43K-10,761,800.00%-107.62K---334.79K-----------112.81K--1
Cash from discontinued financing activities
Financing cash flow -109.57%-25.39K--------237.68%4.73M281,738,200.00%2.82M--265.21K--------65,071.77%1.4M--1
Net cash flow
Beginning cash position 35.81%1.88M-57.21%75.82K200.87%1.31M-51.35%436.31K-68.64%255.05K14.70%1.39M-70.84%177.19K-51.35%436.31K-68.10%896.83K-39.61%813.33K
Current changes in cash 6.25%-1.06M49.45%1.81M-377.35%-1.24M290.31%876.43K380.54%1.06M-186.14%-1.13M101.16%1.21M10.41%-259.13K75.95%-460.52K16.21%-377.02K
End cash Position 222.41%822.29K35.81%1.88M-57.21%75.82K200.87%1.31M200.87%1.31M-68.64%255.05K14.70%1.39M-70.84%177.19K-51.35%436.31K-51.35%436.31K
Free cash from 25.87%-1.04M-588.62%-3.03M-377.35%-1.24M-107.07%-3.86M-366.74%-1.76M-253.22%-1.4M45.03%-439.79K10.41%-259.13K2.88%-1.86M16.21%-377.02K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -